Washington – Robitussin cough syrup supplied nationally is being recalled by Haleon owing to microbial contamination that may cause fatal infections in susceptible individuals, the US division of the global consumer health company based in the UK announced this week. “Use of the recalled products could potentially result in severe or life-threatening fungal infections in those with impaired immune systems,” …
Brominated vegetable oil sports drinks, sodas banned by FDA
Washington – The use of brominated vegetable oil, widely used in beverages like Gatorade and Mountain Dew but has been gradually phased out due to its link to possible health risks, including damage to the liver, heart, and brain, was proposed to be outlawed by the Food and Drug Administration (FDA) recently. The FDA declared them as no longer safe …
Narcan to be available as over-the-counter drug
Washington – The overdose reversal drug Narcan manufacturer announced the Food and Drug Administration (FDA) approved nasal spray and it will be available for over-the-counter purchase starting in September. According to Biotech company Emergent BioSolutions, the Narcan nasal spray has already been shipped to pharmacies, drugstores, grocery stores and online retailers.
FDA warns against 2 brands of eyedrops
Washington – The Food and Drug Administration (FDA) issued a warning to consumers not to use certain kinds of eyedrops as they may include unapproved medications that cannot be sold legally in the US and may be infected with bacteria, fungus, or both. Consumers were advised not to use Dr Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops. …
FDA approves first postnatal depression pill
Washington – The Food and Drug Administration (FDA) has given approval for the zuranolone, sold under the brand name Zurzuvae, to be used as a pill to treat postnatal depression as alternative to intravenous injection. The drug can be taken by patients as a once-daily pill for two weeks and, per drug manufacturers Sage Therapeutics and Biogen’s direction. The pill …
Beyfortus approved in US for prevention of respiratory tract disease in kids
London – AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the US for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Beyfortus will be available …
US facing widespread shortages of cancer drugs
Washington – The US is facing widespread shortages of cancer drugs. As a result the doctors are rationing doses and turning to other treatment options that may have severer side effects. Food and Drug Administration (FDA) has listed 14 cancer drugs in shortage in the US. Between 2021 and 2022, there was an “almost 30% increase in new medicine shortages.” …